SGS Life Science Services has opened three new offices in Poland, Czech Republic and Romania.
As a further step in the initiative to expand its Global Clinical Development (GCD) services, SGS Life Science Services has opened three new offices in Poland, Czech Republic and Romania. The offices located in Warsaw, Prague, and Bucharest, respectively, will provide services for clinical trial monitoring, study feasibility, and site selection, as well as support the regulatory aspects in these countries.
“The opening of the new offices addresses the request of many of our sponsors to conduct trials in Central & Eastern Europe in order to benefit from the vast pool of treatment naïve patients, faster enrolment times, and the cost benefits these countries offer,” said Luc Braeken, VP of Global Clinical Development. “Highly qualified and motivated investigators, low drop out rates of enrolled patients and the high quality of the clinical data are additional advantages of conducting trials in Central and Eastern Europe.”
The offices are staffed with highly knowledgeable teams with broad experience in conducting clinical trials in the pharmaceutical and CRO industry as well as in academia. Lead by seasoned MDs, the teams cover a wide range of therapeutic areas with special emphasis in CNS, Infectious Disease and Cardiovascular Disease, SGS’ areas of core expertise.
Complementary services including Project Management, Data Management & Statistics, Regulatory Affairs, and Medical Affairs will be provided from SGS’ main office for GCD in Belgium with more than 400 people.
Sales & Marketing Vice President
1 place des Alpes, P.O. Box 2152, CH - 1211 Geneva
t: + 41 22 739 9411
f: +41 22 739 98 86
The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognized as the global benchmark in quality and integrity. With more than 50,000 employees, SGS operates a network of over 1,000 offices and laboratories around the world.